Genetic variant in visfatin gene promoter contributes to reduced risk of hepatocellular carcinoma in a Chinese population

4Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Knowledge on the role of gene variants in the visfatin promoter region in the hepatitis B virus (HBV)-related liver diseases is limited. In this study, we genotyped two potentially functional single nucleotide polymorphisms (SNPs) in the visfatin promoter region, -1535C > T (rs61330082) and -3187G > A (rs11977021), in 120 HBVrelated chronic hepatitis B (CHB) patients, 140 HBV-related liver cirrhosis (HBVLC) patients, 243 HBV-related hepatocellular carcinoma (HBV-HCC) patients, and 224 asymptomatic HBV carriers. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated by logistic regression. The results showed subjects with a TT genotype of -1535C > T had a significantly decreased risk of HBV-HCC related to the CC and CC + CT genotypes (adjusted OR = 0.493, 95% CI = 0.313-0.778; OR = 0.535, 95% CI = 0.362-0.791, respectively). A lowered risk also appeared in the comparison between allele T and allele C (OR = 0.734, 95%, CI = 0.581-0.950). However, these associations existed only in people with Zhuang ethnicity, but not in people with Han ethnicity. There were no significant associations between -3187G > A polymorphisms and the risk of HBV-related liver diseases. Our results suggested that visfatin -1535C > T polymorphisms might be associated with decreased risk of HBVHCC among the ethnic Zhuang population in Guangxi, China.

Cite

CITATION STYLE

APA

Wu, Z., Sun, Y., Huang, Y., Zhu, S., Feng, Y., Ye, H., … Tang, S. (2016). Genetic variant in visfatin gene promoter contributes to reduced risk of hepatocellular carcinoma in a Chinese population. Oncotarget, 7(47), 77968–77977. https://doi.org/10.18632/oncotarget.12864

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free